Design Therapeutics, Inc. (DSGN) net assets (shareholders' equity)

Net assets · fiscal 2025
$212.50M

Design Therapeutics, Inc. (DSGN) had net assets of $212.50M at the end of fiscal 2025 (December 31, 2025). That is 12.2% lower than the $242.10M of fiscal 2024. Figures as of 19 Nov 2026, 11:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$212.50M
Change on fiscal 2024
−12.2%
Highest on record
$382.13Mfiscal 2021
Lowest on record
-$11.32Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Design Therapeutics, Inc. net assets (shareholders' equity), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $382.13M in fiscal 2021 and the lowest -$11.32M in fiscal 2020.

History · 6 fiscal years

Net assets by fiscal year

Design Therapeutics, Inc. net assets (shareholders' equity), year by year

Design Therapeutics, Inc. (DSGN) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$212.50M 12.2% down
2024$242.10M 12.8% down
2023$277.69M 15.2% down
2022$327.31M 14.3% down
2021$382.13M—
2020-$11.32M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

More on DSGN

Design Therapeutics, Inc., figure by figure

Design Therapeutics, Inc. (DSGN) overview: price, valuation and scorecard

Design Therapeutics, Inc. net assets (shareholders' equity): questions and answers

What are Design Therapeutics, Inc.'s net assets?

Design Therapeutics, Inc. (DSGN) had net assets of $212.50M at the end of fiscal 2025 (December 31, 2025). That is 12.2% lower than the $242.10M of fiscal 2024.

What are the highest and lowest net assets figures on record for Design Therapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was $382.13M in fiscal 2021 and the lowest -$11.32M in fiscal 2020.

How is Design Therapeutics, Inc.'s net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Design Therapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Design Therapeutics, Inc. (DSGN) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/DSGN/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.